The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 11,352.00
Bid: 11,348.00
Ask: 11,350.00
Change: 84.00 (0.75%)
Spread: 2.00 (0.018%)
Open: 11,288.00
High: 11,412.00
Low: 11,288.00
Prev. Close: 11,268.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

12 Aug 2021 12:29

Cambodia starts vaccine booster drive to shore up COVID-19 defence

By Chantha LachPHNOM PENH, Aug 12 (Reuters) - Cambodia started offering coronavirus vaccine booster shots on Thursday in a renewed public health drive after managing to inoculate more than half of its population.One of Asia's poorest countries, Ca...

Read more
12 Aug 2021 12:11

JP Morgan restarts AstraZeneca at overweight, sees re-rating opportunity

(Sharecast News) - Analysts at JP Morgan resumed their coverage of AstraZeneca at 'overweight', telling clients they saw a "re-rating opportunity".

Read more
12 Aug 2021 12:09

Thursday broker round-up

(Sharecast News) - Hill&Smith: Berenberg keeps at buy and raises target price from 1,775.0p to 1,995.0p.

Read more
12 Aug 2021 09:41

LONDON BROKER RATINGS: Bank of America resumes Flutter At Buy

LONDON BROKER RATINGS: Bank of America resumes Flutter At Buy

Read more
12 Aug 2021 08:18

LONDON BRIEFING: UK economy continues post-pandemic rebound

LONDON BRIEFING: UK economy continues post-pandemic rebound

Read more
11 Aug 2021 22:00

Age restrictions on AstraZeneca shot have ended reports of rare clots -UK scientists

LONDON, Aug 11 (Reuters) - No new cases of a rare and severe blood clots following vaccination with AstraZeneca's COVID shot have been reported in Britain in recent weeks after a decision to restrict its use in under-40s, British scientists said ...

Read more
11 Aug 2021 15:10

UPDATE 2-EU looking into new possible side-effects of mRNA COVID-19 shots

* Skin rash, two kidney disorders being studied by EMA* Requested more data from Pfizer, Moderna* Has not recommended label changes (Adds detail throughout)By Pushkala AripakaAug 11 (Reuters) - Three new conditions reported by a small number of peo...

Read more
11 Aug 2021 14:51

US watchdog requests additional safety trial of Astra's roxadustat

US watchdog requests additional safety trial of Astra's roxadustat

Read more
10 Aug 2021 18:47

Oxford researcher urges Britain to donate vaccines rather than give boosters

LONDON, Aug 10 (Reuters) - Booster shots for COVID-19 vaccines are not currently needed and the doses should be given to other countries, Oxford vaccine chief Andrew Pollard said on Tuesday in contrast to the position taken by Britain's health mi...

Read more
9 Aug 2021 13:01

UPDATE 1-BioNTech says has supplied more than 1 bln COVID-19 vaccine doses so far

(Adds changes to estimates, details on Pfizer)By Ludwig BurgerFRANKFURT, Aug 9 (Reuters) - BioNTech and partner Pfizer have supplied more than one billion doses of their COVID-19 vaccine as per July 21, a bigger number than delivered by competitor...

Read more
9 Aug 2021 13:01

UPDATE 2-BioNTech says vaccine repeats beat devising new one for now

(Adds rationale on third shot)By Ludwig BurgerFRANKFURT, Aug 9 (Reuters) - BioNTech said that repeat shots of its COVID-19 vaccine, of which more than a billion doses have now been supplied worldwide, was a better strategy than tailoring the produ...

Read more
9 Aug 2021 12:00

BioNTech says has supplied more than 1 bln COVID-19 vaccine doses so far

FRANKFURT, Aug 9 (Reuters) - BioNTech and partner Pfizer have supplied more than one billion doses of their COVID-19 vaccine as per July 21, a bigger number than delivered by competitor AstraZeneca, the German biotech group said on Monday.AstraZe...

Read more
9 Aug 2021 09:42

LONDON BROKER RATINGS: Liberum says buy Made.com; RBC cuts ConvaTec

LONDON BROKER RATINGS: Liberum says buy Made.com; RBC cuts ConvaTec

Read more
9 Aug 2021 08:49

LONDON MARKET OPEN: Hargreaves Lansdown falls on higher costs warning

LONDON MARKET OPEN: Hargreaves Lansdown falls on higher costs warning

Read more
9 Aug 2021 08:46

AstraZeneca's Forxiga gets EU approval for kidney disease treatment

AstraZeneca's Forxiga gets EU approval for kidney disease treatment

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.